ZT
Zoetis
ZTS · NYSE
$73.56 -2.97% (-$2.25)
1M -1.70%
Market Cap $32.0B
P/E Ratio 12.22x
Div. Yield 2.74%
ROE 69.25%
Bulios Fair Price
$86.93
18.2% upside
Trenutna cena
$73.56
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ZTS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
73 /100
Cheap P/E 12.22x
PEG 1.59x
EV/EBITDA 10.26x
Growth
58 /100
Stable EPS growth 10.27%
Book val. growth 8.89%
Rev. growth 5.42%
Profitability
100 /100
Strong Gross margin 70.87%
FCF margin 24.86%
Net margin 27.49%
Quality
93 /100
Excellent ROIC 21.63%
Asset turnover 0.63x
ROE 69.25%
Debt
57 /100
Moderate Debt/Equity 2.93x
Net debt/EBITDA 2.00x
Current ratio 3.08x
Stability
100 /100
Stable Beta 0.73x
Profitable years 6
Rev. volatility 3.04%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ZTS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kristin C. Peck
Employees
14,500
Headquarters
Parsippany
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report